These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1538 related items for PubMed ID: 29947322
21. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Dixon JB, Bhathal PS, O'Brien PE. Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735 [Abstract] [Full Text] [Related]
24. A weight-loss Mediterranean diet/lifestyle intervention ameliorates inflammation and oxidative stress in patients with obstructive sleep apnea: results of the "MIMOSA" randomized clinical trial. Georgoulis M, Yiannakouris N, Tenta R, Fragopoulou E, Kechribari I, Lamprou K, Perraki E, Vagiakis E, Kontogianni MD. Eur J Nutr; 2021 Oct; 60(7):3799-3810. PubMed ID: 33839919 [Abstract] [Full Text] [Related]
30. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. Kazankov K, Møller HJ, Lange A, Birkebaek NH, Holland-Fischer P, Solvig J, Hørlyck A, Kristensen K, Rittig S, Handberg A, Vilstrup H, Grønbaek H. Pediatr Obes; 2015 Jun; 10(3):226-33. PubMed ID: 25073966 [Abstract] [Full Text] [Related]
31. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study. Chen LW, Huang MS, Shyu YC, Chien RN. Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481 [Abstract] [Full Text] [Related]
34. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. Khoo J, Hsiang J, Taneja R, Law NM, Ang TL. Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750 [Abstract] [Full Text] [Related]
39. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial. Properzi C, O'Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, Tibballs J, MacQuillan GC, Garas G, Adams LA. Hepatology; 2018 Nov; 68(5):1741-1754. PubMed ID: 29729189 [Abstract] [Full Text] [Related]
40. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]